Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that careful history and physical exams are crucial for accurately diagnosing polycystic ovary syndrome and distinguishing it from other similar conditions.

The document concludes that sex hormones and related compounds have various effects on health, with both potential benefits and risks.

Metformin is safe in early pregnancy for women with PCOS and may reduce certain risks.

The document concludes that proper diagnosis and treatment of nonscarring alopecias can improve quality of life and hair regrowth is possible as the hair follicle remains intact.

The document concludes that early diagnosis and treatment of PCOS in teenagers is important for managing symptoms and preventing long-term health problems.

The document concludes that treating skin conditions should include psychological care and a multidisciplinary approach is essential for effective management.

Antiyeast treatments work better for seborrheic dermatitis than steroids, and other findings include increased skin bacteria under plastic wrap, a nasal cell defect in Staphylococcus aureus carriers, quick resolution of certain skin reactions, high rubber latex allergy in spina bifida patients, and glyceryl monopentadecanoate's effectiveness for male hair loss.

Cyproterone acetate is used to treat conditions like prostate cancer, early puberty, excessive sexual drive, and female androgenization by affecting androgen functions and suppressing certain hormones.

About 7% to 15% of Iranian women have polycystic ovary syndrome, depending on the criteria used to diagnose it.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Hirsutism is a strong sign of high male hormones and metabolic problems in women with PCOS, but acne and hair loss are not.

A postmenopausal woman's hair loss and excess hair growth improved after surgery for ovarian hyperthecosis.

Stem cell treatments can potentially treat baldness, with one trial showing hair growth after injecting a hair-stimulating complex, and no safety issues were reported.

The article concludes that hormonal therapy is an effective long-term acne treatment, even for those without hormonal imbalances.

Men with early hair loss may have a higher risk of enlarged prostate and possibly prostate cancer due to shared hormonal factors.

Hormonal imbalances can cause skin and hair problems in women, and treatments that block male hormones can help.

Women with PCOS should be screened for heart disease risk and manage their health to prevent it.

Norgestimate is the most effective birth control progestin for reducing an enzyme linked to acne and excessive hair growth in women.

Many women with hard-to-treat acne also have PCOS.

Reducing granulosa cell pyroptosis may improve oocyte maturation in PCOS.

The chapter explains the causes of excessive hair growth and masculinization in women and how to measure hormone levels related to these conditions.

Non-invasive imaging helped diagnose a woman's severe hormone imbalance and diabetes, and medication successfully treated her condition.

PCOS affects a similar percentage of Black and White women in the Southeastern United States.

Women with epilepsy should be monitored for reproductive issues, which can be caused by epilepsy or its treatments, especially when using valproate.

Male hormones affect oil-producing skin cells differently based on their body location, and the drug spironolactone can reduce these effects.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

Obese and lean women with PCOS have different symptoms and need different treatments.

Phytotherapeutic compounds and supplements can help manage Polycystic Ovarian Syndrome (PCOS).

Skin infections and rashes are the most common skin problems in children.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.